Xin Lang Zheng Quan
Search documents
包钢股份涨2.06%,成交额4.87亿元,主力资金净流入4961.26万元
Xin Lang Zheng Quan· 2026-01-06 02:00
Core Viewpoint - Baosteel Co., Ltd. has shown a mixed performance in stock price and financial results, with a notable increase in net profit despite a decline in revenue [1][2]. Group 1: Stock Performance - On January 6, Baosteel's stock price increased by 2.06%, reaching 2.48 CNY per share, with a trading volume of 4.87 billion CNY and a turnover rate of 0.63%, resulting in a total market capitalization of 112.316 billion CNY [1]. - Year-to-date, Baosteel's stock price has risen by 4.20%, with a 3.33% increase over the last five trading days, a 0.40% increase over the last 20 days, and a 2.36% decline over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Baosteel reported an operating revenue of 48.08 billion CNY, a year-on-year decrease of 3.58%, while the net profit attributable to shareholders increased by 145.03% to 233 million CNY [2]. - Since its A-share listing, Baosteel has distributed a total of 4.487 billion CNY in dividends, with 90.577 million CNY distributed over the past three years [3]. Group 3: Shareholder Structure - As of December 19, Baosteel had 869,100 shareholders, a decrease of 2.65% from the previous period, with an average of 36,105 circulating shares per shareholder, an increase of 2.73% [2]. - The second-largest shareholder is China Securities Finance Corporation, holding 767 million shares, while Hong Kong Central Clearing Limited, the third-largest shareholder, reduced its holdings by 574 million shares [3].
波长光电涨2.02%,成交额1.69亿元,主力资金净流入132.15万元
Xin Lang Zheng Quan· 2026-01-06 01:57
波长光电所属申万行业为:电子-光学光电子-光学元件。所属概念板块包括:光刻机、光刻胶、光学、 激光雷达、3D打印等。 截至9月30日,波长光电股东户数4.43万,较上期增加63.76%;人均流通股1045股,较上期减少 38.94%。2025年1月-9月,波长光电实现营业收入3.45亿元,同比增长24.66%;归母净利润2576.43万 元,同比减少16.39%。 分红方面,波长光电A股上市后累计派现6017.34万元。 机构持仓方面,截止2025年9月30日,波长光电十大流通股东中,永赢半导体产业智选混合发起A (015967)位居第一大流通股东,持股200.00万股,持股数量较上期不变。香港中央结算有限公司位居 第二大流通股东,持股110.27万股,相比上期增加44.20万股。金信稳健策略混合A(007872)位居第三 大流通股东,持股100.00万股,相比上期减少68.20万股。德邦半导体产业混合发起式A(014319)位居 第三大流通股东,持股100.00万股,相比上期减少20.00万股。富国创新科技混合A(002692)位居第五 大流通股东,持股30.00万股,为新进股东。金信精选成长混合A(018 ...
宇信科技1月5日获融资买入9943.30万元,融资余额9.65亿元
Xin Lang Zheng Quan· 2026-01-06 01:28
1月5日,宇信科技跌1.20%,成交额6.28亿元。两融数据显示,当日宇信科技获融资买入额9943.30万 元,融资偿还8609.16万元,融资净买入1334.14万元。截至1月5日,宇信科技融资融券余额合计9.68亿 元。 融资方面,宇信科技当日融资买入9943.30万元。当前融资余额9.65亿元,占流通市值的5.72%,融资余 额超过近一年50%分位水平,处于较高位。 融券方面,宇信科技1月5日融券偿还0.00股,融券卖出2.65万股,按当日收盘价计算,卖出金额63.52万 元;融券余量11.07万股,融券余额265.35万元,超过近一年70%分位水平,处于较高位。 资料显示,北京宇信科技集团股份有限公司位于北京市朝阳区酒仙桥东路9号院电子城研发中心A2楼东 5-6层,北京市朝阳区建国门外大街1号国贸大厦A座2601室,香港湾仔皇后大道东248号大新金融中心40 楼,成立日期2006年10月19日,上市日期2018年11月7日,公司主营业务涉及从事向以银行为主的金融 机构提供包括咨询、软件产品、软件开发和实施、运营维护、系统集成等信息化服务。主营业务收入构 成为:银行IT解决方案84.94%,非银IT解决 ...
兴瑞科技1月5日获融资买入2435.12万元,融资余额3.33亿元
Xin Lang Zheng Quan· 2026-01-06 01:28
Group 1 - The core business of Ningbo Xingsui Electronic Technology Co., Ltd. focuses on precision electronic components and mold products, with revenue contributions from automotive electronics (52.32%), smart terminals (26.26%), and other sectors [2] - As of September 30, 2025, the company reported a revenue of 1.328 billion yuan, a year-on-year decrease of 10.13%, and a net profit attributable to shareholders of 119 million yuan, down 38.42% year-on-year [2] - The company has distributed a total of 495 million yuan in dividends since its A-share listing, with 298 million yuan distributed in the last three years [3] Group 2 - On January 5, 2025, Xingsui Technology's stock rose by 0.72%, with a trading volume of 149 million yuan [1] - The financing buy-in amount on January 5 was 24.35 million yuan, with a net financing buy of 7.52 million yuan, and the total financing balance reached 333 million yuan, accounting for 4.70% of the circulating market value [1] - The company’s margin trading and securities lending balance is at a high level, exceeding the 90th percentile over the past year [1]
天奥电子1月5日获融资买入9421.21万元,融资余额4.20亿元
Xin Lang Zheng Quan· 2026-01-06 01:26
Core Viewpoint - Tianao Electronics experienced a decline of 1.12% in stock price on January 5, with a trading volume of 639 million yuan, indicating a potential concern in market sentiment towards the company [1]. Financing Summary - On January 5, Tianao Electronics had a financing buy-in amount of 94.21 million yuan, with a net financing buy of 26.68 million yuan after repayments [1]. - The total financing and securities balance reached 420 million yuan, accounting for 4.50% of the circulating market value, which is above the 50th percentile level over the past year, indicating a relatively high financing level [1]. - In terms of securities lending, there were no shares repaid, with 5,200 shares sold short, amounting to 114,900 yuan at the closing price, and a securities lending balance of 324,900 yuan, which is above the 90th percentile level over the past year [1]. Company Performance - As of September 30, the number of shareholders for Tianao Electronics was 20,700, a decrease of 10.67% from the previous period, while the average circulating shares per person increased by 11.95% to 20,055 shares [2]. - For the period from January to September 2025, the company reported a revenue of 536 million yuan, a year-on-year decrease of 7.12%, and a net profit attributable to shareholders of 15.22 million yuan, down 4.51% year-on-year [2]. Dividend Information - Since its A-share listing, Tianao Electronics has distributed a total of 233 million yuan in dividends, with 91.17 million yuan distributed over the past three years [3]. Shareholding Structure - As of September 30, 2025, Hong Kong Central Clearing Limited was the seventh largest circulating shareholder, holding 2.9434 million shares as a new shareholder [3].
迈瑞医疗1月5日获融资买入2.86亿元,融资余额38.05亿元
Xin Lang Zheng Quan· 2026-01-06 01:26
Summary of Key Points Core Viewpoint - On January 5, 2025, Mindray Medical saw a stock increase of 4.80% with a trading volume of 3.339 billion yuan, indicating strong market interest despite a net financing outflow of 100 million yuan on that day [1]. Group 1: Financial Performance - For the period from January to September 2025, Mindray Medical reported a revenue of 25.834 billion yuan, reflecting a year-on-year decrease of 12.38% [2]. - The net profit attributable to shareholders for the same period was 7.570 billion yuan, down 28.83% year-on-year [2]. Group 2: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Mindray Medical reached 108,800, an increase of 18.86% compared to the previous period [2]. - The average number of circulating shares per shareholder was 11,139, which decreased by 15.87% from the previous period [2]. Group 3: Financing and Margin Trading - On January 5, 2025, Mindray Medical had a total margin trading balance of 3.866 billion yuan, with a financing balance of 3.805 billion yuan, accounting for 1.57% of the circulating market value [1]. - The company’s margin trading balance is above the 80th percentile of the past year, indicating a high level of trading activity [1]. Group 4: Dividend Distribution - Since its A-share listing, Mindray Medical has distributed a total of 35.336 billion yuan in dividends, with 25.025 billion yuan distributed over the last three years [3]. Group 5: Institutional Holdings - As of September 30, 2025, the third-largest circulating shareholder was Hong Kong Central Clearing Limited, holding 117 million shares, a decrease of 14.736 million shares from the previous period [3]. - Other notable institutional shareholders, such as E Fund and Huatai-PB, also reported reductions in their holdings [3].
天风证券1月5日获融资买入6700.87万元,融资余额20.92亿元
Xin Lang Zheng Quan· 2026-01-06 01:26
Core Viewpoint - Tianfeng Securities has shown a mixed performance in financing and margin trading activities, with a notable increase in revenue and net profit year-on-year, indicating potential growth opportunities in the securities industry [1][2]. Financing Summary - On January 5, Tianfeng Securities recorded a financing buy amount of 67.01 million yuan and a financing repayment of 65.20 million yuan, resulting in a net financing buy of 1.81 million yuan [1]. - The total financing and margin trading balance reached 2.098 billion yuan, with the financing balance accounting for 5.78% of the circulating market value, which is below the 30% percentile level over the past year, indicating a low position [1]. - The company repaid 68,800 shares in margin trading and sold 176,800 shares on the same day, with a selling amount of 744,300 yuan, while the margin trading balance was 5.87 million yuan, also below the 10% percentile level over the past year [1]. Company Profile - Tianfeng Securities, established on March 29, 2000, and listed on October 19, 2018, is located in Wuhan, Hubei Province, and its main business includes securities brokerage, investment consulting, financial advisory related to securities transactions, and margin trading [2]. - The revenue composition of Tianfeng Securities includes 55.47% from securities brokerage, 40.06% from proprietary trading, 34.81% from investment banking, and 14.23% from asset management [2]. - As of September 30, 2025, the company reported a total revenue of 2.112 billion yuan, a year-on-year increase of 57.53%, and a net profit attributable to shareholders of 153 million yuan, reflecting a significant growth of 128.55% year-on-year [2]. Dividend and Shareholding Summary - Since its A-share listing, Tianfeng Securities has distributed a total of 171 million yuan in dividends, with no dividends paid in the last three years [3]. - As of September 30, 2025, the top ten circulating shareholders include the Guotai CSI All-Index Securities Company ETF, which holds 183 million shares, an increase of 7.44 million shares from the previous period [3]. - Other notable shareholders include the Huabao CSI All-Index Securities Company ETF and the Southern CSI 500 ETF, with respective holdings of 119 million shares and 103 million shares, showing changes in their shareholdings compared to the previous period [3].
长城证券1月5日获融资买入4191.59万元,融资余额14.49亿元
Xin Lang Zheng Quan· 2026-01-06 01:23
1月5日,长城证券涨1.37%,成交额3.29亿元。两融数据显示,当日长城证券获融资买入额4191.59万 元,融资偿还4934.47万元,融资净买入-742.88万元。截至1月5日,长城证券融资融券余额合计14.51亿 元。 融资方面,长城证券当日融资买入4191.59万元。当前融资余额14.49亿元,占流通市值的3.89%,融资 余额超过近一年60%分位水平,处于较高位。 融券方面,长城证券1月5日融券偿还1.54万股,融券卖出1.88万股,按当日收盘价计算,卖出金额19.44 万元;融券余量13.69万股,融券余额141.55万元,低于近一年10%分位水平,处于低位。 截至12月19日,长城证券股东户数12.68万,较上期减少2.76%;人均流通股28403股,较上期增加 2.84%。2025年1月-9月,长城证券实现营业收入41.21亿元,同比增长44.61%;归母净利润19.31亿元, 同比增长75.83%。 分红方面,长城证券A股上市后累计派现34.36亿元。近三年,累计派现16.98亿元。 机构持仓方面,截止2025年9月30日,长城证券十大流通股东中,香港中央结算有限公司位居第四大流 通股东, ...
捷昌驱动1月5日获融资买入5014.44万元,融资余额5.37亿元
Xin Lang Zheng Quan· 2026-01-06 01:23
1月5日,捷昌驱动跌0.03%,成交额2.88亿元。两融数据显示,当日捷昌驱动获融资买入额5014.44万 元,融资偿还5350.62万元,融资净买入-336.18万元。截至1月5日,捷昌驱动融资融券余额合计5.39亿 元。 融资方面,捷昌驱动当日融资买入5014.44万元。当前融资余额5.37亿元,占流通市值的3.69%,融资余 额超过近一年70%分位水平,处于较高位。 截至9月30日,捷昌驱动股东户数5.01万,较上期增加19.50%;人均流通股7634股,较上期减少 16.32%。2025年1月-9月,捷昌驱动实现营业收入30.35亿元,同比增长18.19%;归母净利润3.80亿元, 同比增长29.63%。 分红方面,捷昌驱动A股上市后累计派现6.85亿元。近三年,累计派现2.80亿元。 机构持仓方面,截止2025年9月30日,捷昌驱动十大流通股东中,香港中央结算有限公司位居第六大流 通股东,持股516.29万股,相比上期减少315.68万股。鹏华碳中和主题混合A(016530)退出十大流通 股东之列。 责任编辑:小浪快报 融券方面,捷昌驱动1月5日融券偿还0.00股,融券卖出0.00股,按当日收盘价计 ...
鹏鼎控股1月5日获融资买入2.35亿元,融资余额13.57亿元
Xin Lang Zheng Quan· 2026-01-06 01:23
1月5日,鹏鼎控股涨2.51%,成交额18.82亿元。两融数据显示,当日鹏鼎控股获融资买入额2.35亿元, 融资偿还2.03亿元,融资净买入3236.80万元。截至1月5日,鹏鼎控股融资融券余额合计13.65亿元。 融资方面,鹏鼎控股当日融资买入2.35亿元。当前融资余额13.57亿元,占流通市值的1.13%,融资余额 超过近一年90%分位水平,处于高位。 分红方面,鹏鼎控股A股上市后累计派现97.25亿元。近三年,累计派现50.97亿元。 机构持仓方面,截止2025年9月30日,鹏鼎控股十大流通股东中,香港中央结算有限公司位居第三大流 通股东,持股8239.70万股,相比上期增加3459.08万股。华泰柏瑞沪深300ETF(510300)位居第五大流 通股东,持股1191.88万股,相比上期减少50.88万股。易方达沪深300ETF(510310)位居第七大流通股 东,持股855.80万股,相比上期减少28.22万股。兴全商业模式混合(LOF)A(163415)、兴全合润混合A (163406)、兴全新视野定期开放混合型发起式(001511)退出十大流通股东之列。 责任编辑:小浪快报 融券方面,鹏鼎控股1月 ...